查看購物車
  • Simplified Chinese
  • English
  • Japanese
北美螢光原位雜合技術成像系統市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶
市場調查報告書
商品編碼
1452565

北美螢光原位雜合技術成像系統市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

North America Fluorescence In-Situ Hybridization Imaging Systems Market Forecast to 2030 - Regional Analysis - By Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 93 Pages | 訂單完成後即時交付

價格

北美螢光原位雜合技術（FISH）成像系統市場預計將從2022年的5.070億美元成長到2030年的8.854億美元。預計2022年至2030年CAGR為7.2%。

魚類影像技術的自動化和數位化推動北美螢光原位雜合技術（魚類）影像系統市場

自動化 FISH 計數系統有助於自動檢測和計數福馬林固定、石蠟包埋的人體組織標本中間期細胞核產生的 FISH 訊號。該系統由標準硬體組件（包括自動掃描顯微鏡和影像分析系統）以及具有 FISH 檢測特定應用程式 (app) 的軟體平台組成。自動 FISH 計數系統設計用於與 IVD 目的的 FISH 測定結合使用，根據細胞的大小、形狀和顏色對細胞進行識別、計數和分類。與手動 FISH 測試計數系統相比，採用自動化技術可能會減少實際操作時間。 FISH 是診斷的黃金標準方法，因為它易於使用並且能夠在樣本採集後當天提供結果。 FISH 成像的自動化、減少的探頭體積和更少的操作時間可能會很快進一步推動 FISH 測試在臨床和研究實驗室中的應用，最終推動更好的患者治療結果。將 FISH 成像與數字病理學平台相結合將促進專家之間的遠端協作並為遠端病理學開闢途徑。成像技術的進步可能會帶來更高解析度的成像、改進的螢光團和複雜的影像分析演算法，從而促進精確的遺傳視覺化並增強 FISH 成像工具。未來，FISH 技術預計將在個人化醫療中發揮重要作用，有助於根據個別基因圖譜制定治療策略。人工智慧和機器學習的整合，從大量資料集中提供見解並預測疾病結果，將進一步放大 FISH 成像的診斷潛力。因此，自動化和數位化很可能成為螢光原位雜合技術（FISH）成像系統市場的重要趨勢。

北美螢光原位雜合技術（魚類）影像系統市場概述

北美螢光原位雜合技術 (FISH) 影像系統市場分為美國、加拿大和墨西哥。目標疾病盛行率的增加推動了對臨床緊急替代方案的需求，從而推動了該地區的市場成長。分子遺傳學和細胞遺傳學領域對先進診斷工具的需求不斷成長，以及遺傳性疾病和癌症盛行率的上升，推動了螢光原位雜合技術 (FISH) 影像系統的採用。根據美國癌症協會2022年公佈的資料，美國約有190萬新診斷癌症病例，609,360人因癌症死亡。這些系統提供遺傳物質的高解析度成像，使研究人員和臨床醫生能夠更準確地檢測染色體異常和基因突變。此外，對個人化醫療和標靶治療的日益關注導致涉及遺傳分析的研究活動激增，從而增加了對 FISH 成像系統的需求。這些系統直接提供細胞內基因序列詳細空間資訊的能力已被證明在研究和臨床應用中具有無價的價值。近年來，FISH 成像系統技術進步的普及程度也有所提高，例如自動化程度的提高、通量的提高以及影像分析軟體的增強。因此，實驗室和醫療機構能夠更好地處理大量樣本並有效產生精確的結果。

北美螢光原位雜合技術（魚類）影像系統市場營收及 2030 年預測（百萬美元）

北美螢光原位雜合技術（魚類）影像系統市場細分

北美螢光原位雜合技術 (FISH) 成像系統市場按產品、應用、最終用戶和國家細分。

根據產品，北美螢光原位雜合技術 (FISH) 影像系統市場分為儀器、耗材、配件和軟體。 2022 年，消耗品領域在北美螢光原位雜合技術 (FISH) 影像系統市場中佔據最大佔有率。

從應用來看，北美螢光原位雜合技術（FISH）影像系統市場細分為癌症診斷、遺傳疾病診斷、傳染病診斷等。 2022年，癌症診斷領域在北美螢光原位雜合技術（FISH）影像系統市場中佔據最大佔有率。

根據最終用戶，北美螢光原位雜合技術 (FISH) 影像系統市場分為診斷實驗室、合約研究組織、製藥和生物技術公司等。 2022 年，診斷實驗室領域在北美螢光原位雜合技術 (FISH) 影像系統市場中佔據最大佔有率。

按國家/地區分類，北美螢光原位雜合技術 (FISH) 成像系統市場分為美國、加拿大和墨西哥。 2022 年，美國將主導北美螢光原位雜合技術 (FISH) 影像系統市場。

Euroclone SpA、TissueGnostics GmbH、安捷倫科技公司、Abnova 台灣公司、BioGenex Laboratories Inc、Leica Biosystems Nussloch GmbH、MetaSystems Probes GmbH、Bio-View Ltd、Thermo Fisher Scientific Inc 和 Applied Spectral Probes GmbH、Bio-View Ltd、Thermo Fisher Scientific Inc 和 Applied Spectral Imaging 是該領域的一些領先公司。原位雜合技術(FISH) 影像系統市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美螢光原位雜合技術 (FISH) 影像系統市場 - 主要產業動態

  • 主要市場促進因素：
    • 目標疾病盛行率上升
    • 增加體外診斷的研發投資
  • 主要市場限制：
    • FISH 成像系統和程序成本高昂
  • 主要市場機會：
    • 螢光原位雜合技術成像的技術進步
  • 未來的趨勢：
    • FISH成像技術的自動化和數位化
  • 影響分析：

第 5 章：螢光原位雜合技術 (FISH) 影像系統市場 - 北美市場分析

  • 北美螢光原位雜合技術 (FISH) 成像系統市場收入，2022 - 2030

第 6 章：北美螢光原位雜合技術 (FISH) 影像系統市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 北美螢光原位雜合技術 (FISH) 成像系統市場收入佔有率（按產品）2022 年和 2030 年 (%)
  • 儀器
  • 耗材
  • 配件
  • 軟體

第 7 章：北美螢光原位雜合技術 (FISH) 影像系統市場 - 2030 年收入和預測 -按應用

  • 概述
  • 北美螢光原位雜合技術 (FISH) 成像系統市場收入佔有率，按應用分類 2022 年和 2030 年 (%)
  • 癌症診斷
  • 遺傳疾病診斷
  • 傳染病診斷
  • 其他

第 8 章：北美螢光原位雜合技術 (FISH) 成像系統市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年北美螢光原位雜合技術 (FISH) 成像系統市場收入佔有率（按最終用戶分類）（%）
  • 診斷實驗室
  • 合約研究組織
  • 製藥和生物技術公司
  • 其他

第 9 章：北美螢光原位雜合技術 (FISH) 影像系統市場 - 國家分析

    • 北美，按國家分類，2022 年和 2030 年 (%)
      • 美國
      • 加拿大
      • 墨西哥

第 10 章：北美螢光原位雜合技術 (FISH) 影像系統市場產業格局

  • 概述
  • 北美螢光原位雜合技術 (FISH) 成像系統市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • PerkinElmer Inc
  • Euroclone SpA

第 12 章：附錄

Product Code: BMIRE00029256

The North America fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 507.0 million in 2022 to US$ 885.4 million by 2030. It is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Automation and Digitalization of Fish Imaging Technique Fuel North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market

An automated FISH enumeration system facilitates the automatic detection and counting of FISH signals generated by interphase nuclei in formalin-fixed, paraffin-embedded human tissue specimens. This system consists of standard hardware components, including an automated scanning microscope and an image analysis system, and software platforms with FISH assay-specific applications (apps). Automated FISH enumeration systems are designed to be used with FISH assays for IVD purposes to identify, count, and classify cells based on their size, shape, and colour. Adopting automated technologies may result in reduced hands-on time compared to manual FISH test enumeration systems. FISH is a gold standard method for diagnostics owing to the ease of use and the ability to provide same-day results after sample collection. The automation of FISH imaging with reduced probe volumes and less hands-on time is likely to further fuel the application of FISH testing in clinical and research laboratories soon, ultimately driving better patient outcomes. Integrating FISH imaging with digital pathology platforms would facilitate remote collaboration among experts and open avenues for telepathology. Advancements in imaging technologies are likely to result in higher-resolution imaging, improved fluorophores, and sophisticated image analysis algorithms, fostering precise genetic visualization and enhancing FISH imaging tools. In the future, FISH technology is anticipated to play an important role in personalized medicine, aiding in tailoring treatment strategies based on individual genetic profiles. The integration of AI and machine learning, offering insights from vast datasets and predicting disease outcomes, would further amplify the diagnostic potential of FISH imaging. Thus, automation and digitalization are likely to emerge as significant trends in the fluorescence in situ hybridization (FISH) imaging systems market.

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Overview

The North American North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is segmented into the US, Canada, and Mexico. An increase in the prevalence of target disorders propels the need for clinical urgency alternatives, which drives the market growth in the region. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems. As per data published by the American Cancer Society in 2022, in US there are around 1.9 million new cancer cases diagnosed and 609,360 cancer deaths. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The popularity of technological advancements in FISH imaging systems, such as improved automation, higher throughput, and enhanced image analysis software, has also increased in recent years. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently.

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Segmentation

The North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.

Based on product, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

In terms of application, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Based on end user, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

By country, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o the US, Canada, and Mexico. The US dominated the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, and Applied Spectral Imaging are some of the leading companies operating in the North America fluorescence in-situ hybridization (FISH) imaging systems market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Target Disorders
    • 4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
  • 4.2 Key Market Restraints:
    • 4.2.1 High Cost of FISH Imaging Systems and Procedures
  • 4.3 Key Market Opportunities:
    • 4.3.1 Technological Advancements in Fluorescence In Situ Hybridization Imaging
  • 4.4 Future Trends:
    • 4.4.1 Automation and Digitalization of FISH Imaging Technique
  • 4.5 Impact Analysis:

5. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - North America Market Analysis

  • 5.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030

6. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Instruments
    • 6.3.1 Overview
    • 6.3.2 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Consumables
    • 6.4.1 Overview
    • 6.4.2 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Accessories
    • 6.5.1 Overview
    • 6.5.2 Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Software
    • 6.6.1 Overview
    • 6.6.2 Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cancer Diagnosis
    • 7.3.1 Overview
    • 7.3.2 Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Genetic Disease Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Infectious Disease Diagnosis
    • 7.5.1 Overview
    • 7.5.2 Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Diagnostic Laboratories
    • 8.3.1 Overview
    • 8.3.2 Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Contract Research Organization
    • 8.4.1 Overview
    • 8.4.2 Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pharmaceutical And Biotechnological Companies
    • 8.5.1 Overview
    • 8.5.2 Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Country Analysis

  • 9.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
    • 9.1.1 Overview
    • 9.1.2 North America , by Country, 2022 & 2030 (%)
      • 9.1.2.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.1 Overview
        • 9.1.2.1.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.3 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.1.3.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.1.3.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.1.4 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.1.5 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.1 Overview
        • 9.1.2.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.3 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.2.3.1 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.2.3.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.2.4 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.2.5 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.1 Overview
        • 9.1.2.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.3.3.1 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.3.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.3.4 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.3.5 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)

10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 TissueGnostics GmbH
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Agilent Technologies Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 BioGenex Laboratories Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Leica Biosystems Nussloch GmbH
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 MetaSystems Probes GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Bio-View Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Thermo Fisher Scientific Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Applied Spectral Imaging
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 PerkinElmer Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Euroclone SpA
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
  • Table 2. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Recent Inorganic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Table 18. Recent Organic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Table 19. Glossary of Terms, North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

List Of Figures

  • Figure 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation, By Country
  • Figure 2. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 6. Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 11. Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 16. Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America , by Country, 2022 & 2030 (%)
  • Figure 22. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market